CoChat
Sign Up
Cited by 236

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Effectiveness of needle and syringe Programmes in people who inject drugs – An overview of systematic reviews

Fernandes, Ricardo M, Cary, Maria, Duarte, Gonçalo, Jesus, Gonçalo, Alarcão, Joana, Torre, Carla, Costa, Suzete, Costa, João, Carneiro, António Vaz·2017·BMC Public Health
DOI 10.1186/s12889-017-4210-2PMC PMC5387338
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12889-017-4210-2

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Screening decisions up to date as of 30Jun2015. Original search date 12May2015
Fig. 1 Screening decisions up to date as of 30Jun2015. Original search date 12May2015CC BY · PubMed Central
Fig. 2 Studies selected for inclusion classified by outcome(s) reported and strategy for data synthesis. *Grey shaded boxes represent the outcome reported in the reviews indicated in the right column. “HIV”, ”HCV” and “Injecting risk behaviours” is used to classify the reviews that reported the impact of NSP in the number of HIV infections, number of HCV infections and change in injection behavior. The reviews are also presented in the right column by strategy used for data synthesis
Fig. 2 Studies selected for inclusion classified by outcome(s) reported and strategy for data synthesis. *Grey shaded boxes represent the outcome reported in the reviews indicated in the right column. “HIV”, ”HCV” and “Injecting risk behaviours” is used to classify the reviews that reported the impact of NSP in the number of HIV infections, number of HCV infections and change in injection behavior. The reviews are also presented in the right column by strategy used for data synthesisCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 47

  1. UNAIDS: UNAIDS: the gap report. 2014.
  2. WHO. Guidance on prevention of viral hepatitis B and c among people who inject drugs. Geneva: WHO; 2007.
  3. Torre C. Syringe exchange Programmes in the context of harm reduction. Arq Med. 2009;23:119–31.
  4. Ball AL, Rana S, Dehne KL. HIV prevention among injecting drug users: responses in developing and transitional countries. Public Health Rep. 1998;113 Suppl:170–81.
  5. van den Hoek JA, van Haastrecht HJ, Coutinho RA. Risk reduction among intravenous drug users in Amsterdam under the influence of AIDS. Am J Public Health. 1989;79:1355–7. · DOI
  6. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: new guidance. London: Medical Research Council; 2008.
  7. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). European drug report: data and statistics. Lisbon: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA); 2015.
  8. Gay Men’s Health Crisis. Syringe exchange programs around the world: global context. New York: Gay Men’s Health Crisis; 2009.
  9. National Institute for Health and Care Excellence (NICE). Needle and syringe Programmes, NICE public health guidance, vol. 52. London: National Institute for Health and Care Excellence; 2014.
  10. Sheridan J, Henderson C, Greenhill N, Smith A. Pharmacy-based needle exchange in New Zealand: a review of services. Harm Reduct J. 2005;2:1–9. · DOI
  11. Jones L, Pickering L, Sumnall H, Mcveigh J, Mark A, Bellis M. A review of the effectiveness and cost-effectiveness of needle and syringe Programmes for injecting drug users. 2008, Liverpool: Centre for Public Health, Liverpool John Moores University.
  12. Palmateer N, Kimber J, Hickman M, Hutchinson S, Rhodes T, Goldberg D. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews. Addiction. 2010;105:844–59. · DOI
  13. MacArthur GJ, van Velzen E, Palmateer N, Kimber J, Pharris A, Hope V, Taylor A, Roy K, Aspinall E, Goldberg D, Rhodes T, Hedrich D, Salminen M, Hickman M, Hutchinson SJ. Interventions to prevent HIV and hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness. Int J Drug Policy. 2014;25:34–52. · DOI
  14. Centre for Reviews and Dissemination. Systematic reviews: CRD’s guidance for undertaking reviews in health care. York: Centre for Reviews and Dissemination, University of York; 2008.
  15. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60. · DOI · Paper page
  16. Takacs I, Demetrovics Z. The efficacy of needle exchange programs in the prevention of HIV and hepatitis infection among injecting drug users. Psychiatr Hung. 2009;24:264–81.
  17. De Lima M, Justo L, Formigoni M. Needle exchange in Sao Paulo city: a harm reduction strategy for injection drug users. J Bras Psiquiatr. 2005;54:286–92.
  18. Jones L, Pickering L, Sumnall H, McVeigh J, Bellis MA. Optimal provision of needle and syringe programmes for injecting drug users: a systematic review. Int J Drug Policy. 2010;21:335–42. · DOI
  19. Tilson H, Aramrattana A, Bozzette S, Celentano D, Falco M, Hammett T. Preventing HIV Infecrtion among injecting drug users in high risk countries: an assessment of the evidence. Washington: Institute of Medicine of the National Academies; 2006.
  20. Leonard L, Forrester L, Navarro C, Hansen J, Doucet C. The effectiveness of needle exchange programs in modifying HIV-related outcomes: a systematic review of the evidence 1997–1999. Hamilton: Effective Public Health Practice Project (EPHPP); 1999.
  21. Cross J, Saunders CM, Bartelli D. The effectiveness of educational and needle exchange programs: a meta-analysis of HIV prevention strategies for injecting drug users. Qual Quant. 1998;32:165–80. · DOI
  22. Aspinall E, Nambiar D, Goldberg D, Hickman M, Weir A, Van Velzen E, et al. Are needle and syringe programmes associated with a reduction in hiv transmission among people who inject drugs: a systematic review and meta-analysis. Int J Epidemiol. 2014;43:235–48. · DOI · Paper page
  23. Des Jarlais DC, Feelemyer JP, Modi SN, Abdul-Quader A, Hagan H. High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review. BMC Public Health. 2013;13:53. · DOI
  24. Abdul-Quader AS, Feelemyer J, Modi S, Stein ES, Briceno A, Semaan S, Horvath T, et al. Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review. AIDS Behav. 2013;17:2878–92. · DOI
  25. Kall K, Hermansson U, Amundsen EJ, Ronnback K, Ronnberg S. The Effectiveness of Needle Exchange Programmes for HIV Prevention A Critical Review. J Glob Drug Policy Pract. 2007;1(3). http://www.globaldrugpolicy.org/Issues/Vol%201%20Issue%203/The%20Effectiveness%20of%20Needle%20Exchange.pdf . Accessed 20 Aug 2015.
  26. Hong Y, Li X. HIV/AIDS behavioral interventions in China: a literature review and recommendation for future research. AIDS Behav. 2009;13:603–13. · DOI
  27. Turner KME, Hutchinson S, Vickerman P, Hope V, Craine N, Palmateer N, et al. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. Addiction. 2011;106:1978–88. · DOI
  28. Wright NMJ, Tompkins CNE. A review of the evidence for the effectiveness of primary prevention interventions for hepatitis C among injecting drug users. Harm Reduct J. 2006;3:27. · DOI
  29. Gibson DR, Flynn NM, Perales D. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS. 2001;15:1329–41. · DOI
  30. Miller CL, Tyndall M, Spittal P, Li K, Palepu A, Schechter MT. Risk-taking behaviors among injecting drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchanges. J Urban Health. 2002;79:257–65. · DOI
  31. Singer M, Himmelgreen D, Weeks MR, Radda KE, Martinez R. Changing the environment of AIDS risk: findings on syringe exchange and pharmacy sales of syringes in Hartford, CTs. Med Anthropol. 1997;18:107–30. · DOI
  32. Van Den Berg C, Smit C, Van Brussel G, Coutinho R, Prins M. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam cohort studies among drug users. Addiction. 2007;102:1454–62. · DOI
  33. Bruneau J, Lamothe F, Franco E, Lachance N, Désy M, Soto J, et al. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study. Am J Epidemiol. 1997;146:994–1002. · DOI
  34. Strathdee S, Patrick D, Currie S, Cornelisse P, Rekart M, Montaner J, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS. 1997;11:f59–65. · DOI
  35. Wright N, Millson C. What is the evidence for the effectiveness of interventions to reduce hepatitis C infection and the associated morbidity. Copenhagen: World Health Organization Europe; 2005.
  36. Fisher DG, Fenaughty AM, Cagle HH, Wells RS. Needle exchange and injection drug use frequency: a randomized clinical trial. J Acquir Immune Defic Syndr. 2003;33:199–205. · DOI
  37. Masson C, Sorensen J, Perlman D, Shopshire M, Delucchi K, Chen T, et al. Hospital- versus community-based syringe exchange: a randomized controlled trial. AIDS Educ Prev. 2007;19:97–100. · DOI
  38. Cox J, De P, Morissette C, Tremblay C, Stephenson R, Allard R, et al. Low perceived benefits and self-efficacy are associated with hepatitis C virus (HCV) infection-related risk among injection drug users. Soc Sci Med. 2008;66:211–20. · DOI
  39. Heinzerling KG, Kral AH, Flynn NM, Anderson RL, Scott A, Gilbert ML, et al. Human immunodeficiency virus and hepatitis C virus testing services at syringe exchange programs: availability and outcomes. J Subst Abus Treat. 2007;32:423–9. · DOI
  40. Kral AH. What is it about needle and syringe programmes that make them effective for preventing HIV transmission? Int J Drug Policy. 2003;14:361–3. · DOI
  41. Small W. Examining barriers to syringe access among injection drug users. Int J Drug Policy. 2005;16:291–2. · DOI
  42. WHO. Policy guidelines for collaborative TB and HIV Services for Injecting and Other Drug Users – an integrated approach. Geneva: World Health Organization, United Nations Office on Drugs and Crime; 2008.
  43. Coffin P. Syringe availability as HIV prevention: a review of modalities. J Urban Health. 2000;77:306–30. · DOI
  44. Moatti JP, Vlahov D, Feroni I, Perrin V, Obadia Y. Multiple access to sterile syringes for injection drug users: vending machines, needle exchange programs and legal pharmacy sales in Marseille, France. Eur Addict Res. 2001;7:40–5. · DOI
  45. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Harm reduction overview for Ireland. Lisbon: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA); 2016.
  46. Hartling L, Vandermeer B, Fernandes RM. Systematic reviews, overviews of reviews and comparative effectiveness reviews: a discussion of approaches to knowledge synthesis. Evid-Based Child Heal. 2014;9:486–94. · DOI
  47. Hartling L, Chisholm A, Thomson D, Dryden DM. A descriptive analysis of overviews of reviews published between 2000 and 2011. PLoS One. 2012;7:e49667. http://dx.doi.org/10.1371/journal.pone.0049667 . · DOI · Paper page

Cited by

Sorted by citations

See all 236

Metadata

Authors
Fernandes, R. M., Cary, M., Duarte, G., Jesus, G., Alarcão, J., Torre, C., Costa, S., Costa, J., & Carneiro, A. V.
Venue
BMC Public Health
Publisher
Springer Science and Business Media LLC
Published
2017-04-11
Volume
17
Issue
1
ISSN
1471-2458
DOI
10.1186/s12889-017-4210-2
PMC
PMC5387338
Cited by
236
References
5
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review